Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer
Niels Fristrup(Aarhus University Hospital), Lars Dyrskjøt(Aarhus University Hospital)
Cited by 77
Related Papers
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|374
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer
|British Journal of Cancer|2011|47